Cite

HARVARD Citation

    Beccuti, M. et al. (2017). HashClone: a new tool to quantify the minimal residual disease in B-cell lymphoma from deep sequencing data. BMC bioinformatics. 18 (1), pp. 1-12. [Online]. 
  
Back to record